Authors concluded more research is needed to understand both patient level and structural barriers to inequitable access to multiple myeloma (MM) care in Canada.
New data suggest that oncologists are using 70 years as a sharp cutoff for aggressive treatments, but this strategy denies effective treatments to older patients, say researchers.